Impact of Crossover: A Consideration for Initial Access Site Selection

Affiliations

¹ Cardiovascular Medicine Division at the Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: hirshfel@pennmedicine.upenn.edu.
² Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Free article

Editorial

John W Hirshfeld Jr et al. JACC Cardiovasc Interv. 2021.

Free article

. 2021 Feb 22;14(4):374-377.

doi: 10.1016/j.jcin.2020.12.028.

¹ Cardiovascular Medicine Division at the Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: hirshfel@pennmedicine.upenn.edu.
² Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Keywords: acute coronary syndrome(s); crossover; femoral access; percutaneous coronary intervention; radial access.

Conflict of interest statement

Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management.
Gragnano F, Branca M, Frigoli E, Leonardi S, Vranckx P, Di Maio D, Monda E, Fimiani L, Fioretti V, Chianese S, Esposito F, Franzese M, Scalise M, D'Angelo C, Scalise R, De Blasi G, Andò G, Esposito G, Calabrò P, Windecker S, Pedrazzini G, Valgimigli M; MATRIX Trial Investigators. Gragnano F, et al. JACC Cardiovasc Interv. 2021 Feb 22;14(4):361-373. doi: 10.1016/j.jcin.2020.11.042. JACC Cardiovasc Interv. 2021. PMID: 33602431 Clinical Trial.